Adipose CDC1s Contribute to Obesity-associated Inflammation Through STING-dependent IL-12 Production
Overview
Authors
Affiliations
Obesity is associated with chronic low-grade white adipose tissue (WAT) inflammation that can contribute to the development of insulin resistance in mammals. Previous studies have identified interleukin (IL)-12 as a critical upstream regulator of WAT inflammation and metabolic dysfunction during obesity. However, the cell types and mechanisms that initiate WAT IL-12 production remain unclear. Here we show that conventional type 1 dendritic cells (cDC1s) are the cellular source of WAT IL-12 during obesity through analysis of mouse and human WAT single-cell transcriptomic datasets, IL-12 reporter mice and IL-12p70 protein levels by enzyme-linked immunosorbent assay. We demonstrate that cDC1s contribute to obesity-associated inflammation by increasing group 1 innate lymphocyte interferon-γ production and inflammatory macrophage accumulation. Inducible depletion of cDC1s increased WAT insulin sensitivity and systemic glucose tolerance during diet-induced obesity. Mechanistically, endocytosis of apoptotic bodies containing self-DNA by WAT cDC1s drives stimulator of interferon genes (STING)-dependent IL-12 production. Together, these results suggest that WAT cDC1s act as critical regulators of adipose tissue inflammation and metabolic dysfunction during obesity.
Wang Y, Yang S, Zhang S, Yang Y, Li S, Zhang M Front Endocrinol (Lausanne). 2025; 16:1446049.
PMID: 39980852 PMC: 11839430. DOI: 10.3389/fendo.2025.1446049.
Maternal exercise prevents metabolic disorders in offspring mice through SERPINA3C.
Li Y, Li R, Zhu J, Chen M, Mu W, Luo H Nat Metab. 2025; 7(2):401-420.
PMID: 39891022 DOI: 10.1038/s42255-024-01213-6.
Zhang Y, Fu L Front Endocrinol (Lausanne). 2024; 15:1420499.
PMID: 39568808 PMC: 11576183. DOI: 10.3389/fendo.2024.1420499.
Cheng Z, Liu B, Liu X Front Nutr. 2024; 11:1407265.
PMID: 39351493 PMC: 11439728. DOI: 10.3389/fnut.2024.1407265.
No time to die: Epigenetic regulation of natural killer cell survival.
Hermans L, OSullivan T Immunol Rev. 2024; 323(1):61-79.
PMID: 38426615 PMC: 11102341. DOI: 10.1111/imr.13314.